The regulation and functions of Group 1 CD1-restricted T cells
第 1 组 CD1 限制性 T 细胞的调节和功能
基本信息
- 批准号:10779737
- 负责人:
- 金额:$ 66.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-20 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:Activities of Daily LivingAcuteAffectAntigen PresentationAntigen-Presenting CellsAntigensApolipoprotein EAtherosclerosisAttenuatedAutoimmune DiseasesBone MarrowCD1 AntigensCell CompartmentationCellsCellular Metabolic ProcessCharacteristicsChimera organismChronicChronic PhaseClone CellsCommunicable DiseasesDataDevelopmentDietDiseaseExhibitsFamilyGene Expression ProfileGeneral PopulationGenerationsGenetic TranscriptionGrowthHIVHealthHelper-Inducer T-LymphocyteHigh Fat DietHumanHyperlipidemiaImmune responseImmunityIn VitroIndividualInfectionInflammationKineticsLipidsMaintenanceMediatingMemoryModelingMolecularMolecular ProfilingMusMycobacterium tuberculosisMycolic AcidPathogenicityPathway interactionsPeptidesPhenotypePhospholipidsPlayPopulationPropertyPsoriasisPulmonary InflammationRegulationRoleSignal TransductionSkinSpecificityT cell responseT memory cellT-LymphocyteT-Lymphocyte SubsetsThymus GlandTransgenic MiceTransgenic ModelTuberculosisVaccinatedVaccinationWorkantigen-specific T cellsautoreactive T cellautoreactivitycomorbidityfeedingglucose mycolatein vivoinsightmembermicrobialmouse modelnanoparticlenovelresponsetranscriptometuberculosis immunityvaccine development
项目摘要
PROJECT SUMMARY
Group 1 CD1-restricted T cells are members of the unconventional T cell family that recognize self- and
microbial lipid antigens presented by CD1a, CD1b, and CD1c molecules. Group 1 CD1-restricted T cells
have been implicated to play critical roles in various autoimmune and infectious diseases, in particular
Mycobacterium tuberculosis (Mtb) infection. While group 1 CD1-restricted T cells represent a substantial
part of the T cell repertoire in humans, further understanding of their in vivo function and regulation in
immune response has been stymied by the lack of group 1 CD1 expression in mice. We have previously
generated a transgenic mouse model possessing the entire human group 1 CD1 locus (hCD1Tg) and TCR
transgenic mouse models with Mtb lipid and self-lipid specificity. We demonstrated that both mycolic acid
(MA)-specific and self-lipid-specific CD1b-restricted T cells confers protection against Mtb infection. In
addition, chronic activation of CD1b autoreactive T cells can lead to the development of psoriasis-like skin
inflammation in an ApoE-deficient mouse model of hyperlipidemia. As hyperlipidemia is a common condition
in HIV-infected individuals and the general population, we aim to further understand how it may affect the
function of group 1 CD1-restricted T cells during infection using Mtb infection as a model. In Aim 1, TCR
transgenic mouse models in hCD1Tg/LDLR-/- background will be used to determine the impact of diet-
induced hyperlipidemia on self- and microbial lipid-specific T cells and elucidate the molecular and cellular
mechanisms mediate such effect. The impact of hyperlipidemia on the polyclonal group 1 CD1-restricted T
cell responses to Mtb infection will also be determined by comparing bacterial burden, lung inflammation,
and magnitude of autoreactive and Mtb lipid-specific T cell responses in Mtb-infected hCD1Tg/LDLR-/- mice
with or without hyperlipidemia. While peptide-specific T cells are known to have distinct effector and memory
phenotypes, the properties of memory group 1 CD1-restricted T cells remain elusive. In Aim 2, we will
determine functional properties and protective mechanism of memory MA/CD1b-specific T cells generated
in mice vaccinated with MA containing nanoparticle (MA-NP). To identify common features associated with
Mtb-lipid specific memory T cells, we will compare memory MA/CD1b-specific T cells to glucose
monomycolate/CD1b-specific T cells, isolated from a novel TCR transgenic mouse model expressing a
conserved germline-encoded mycolyl lipid-reactive (GEM) TCR. Lasty, the transcriptional and functional
properties of memory MA/CD1b-specific T cells elicited by two vaccination approaches, MA-NP and an
attenuated Mtb strain, will be compared and their response to subsequent challenge with Mtb will be
evaluated. Collectively, these studies will pave way to better understanding of the role of lipid-specific T
cells in various infectious disease in a relevant comorbidity condition.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chyung-Ru Wang其他文献
Chyung-Ru Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chyung-Ru Wang', 18)}}的其他基金
A new mouse model to study the function of CD1b-restricted germline encoded, mycolyl lipid-reactive (GEM) T cells
一种新的小鼠模型,用于研究 CD1b 限制的种系编码的菌基脂质反应性 (GEM) T 细胞的功能
- 批准号:
10727275 - 财政年份:2023
- 资助金额:
$ 66.57万 - 项目类别:
The role of non-classical MHC class I molecules in immune responses to Mycobacterium tuberculosis infection
非经典 MHC I 类分子在结核分枝杆菌感染免疫反应中的作用
- 批准号:
10402266 - 财政年份:2018
- 资助金额:
$ 66.57万 - 项目类别:
The role of non-classical MHC class I molecules in immune responses to Mycobacterium tuberculosis infection
非经典 MHC I 类分子在结核分枝杆菌感染免疫反应中的作用
- 批准号:
9918253 - 财政年份:2018
- 资助金额:
$ 66.57万 - 项目类别:
Development of Lipid-based Nanoparticle Vaccines Against Mycobacterium tuberculosis
抗结核分枝杆菌脂质纳米颗粒疫苗的研制
- 批准号:
9298853 - 财政年份:2017
- 资助金额:
$ 66.57万 - 项目类别:
The Role of Group 1 CD1-Restricted T Cells in Atherosclerosis
第 1 组 CD1 限制性 T 细胞在动脉粥样硬化中的作用
- 批准号:
8603279 - 财政年份:2013
- 资助金额:
$ 66.57万 - 项目类别:
The Role of Group 1 CD1-Restricted T Cells in Atherosclerosis
第 1 组 CD1 限制性 T 细胞在动脉粥样硬化中的作用
- 批准号:
8451723 - 财政年份:2013
- 资助金额:
$ 66.57万 - 项目类别:
Group 1 CD1 in Infectious Disease and T Cell Development
第 1 组 CD1 在传染病和 T 细胞发育中的作用
- 批准号:
6828264 - 财政年份:2003
- 资助金额:
$ 66.57万 - 项目类别:
Group 1 CD1 in Infectious Disease and T Cell Development
第 1 组 CD1 在传染病和 T 细胞发育中的作用
- 批准号:
7152581 - 财政年份:2003
- 资助金额:
$ 66.57万 - 项目类别:
Group 1 CD1 in Infectious Disease and T Cell Development
第 1 组 CD1 在传染病和 T 细胞发育中的作用
- 批准号:
7994164 - 财政年份:2003
- 资助金额:
$ 66.57万 - 项目类别:
Group 1 CD1 in Infectious Disease and T Cell Development
第 1 组 CD1 在传染病和 T 细胞发育中的作用
- 批准号:
7650923 - 财政年份:2003
- 资助金额:
$ 66.57万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 66.57万 - 项目类别:
Standard Grant














{{item.name}}会员




